MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1467057-23-3
MCE 国际站:PF-06409577
产品活性:PF-06409577是有效,选择性的AMPK α1β1γ1 亚型变构激活剂,EC50 值为7 nM。
研究领域:Epigenetics | PI3K/Akt/mTOR
作用靶点:AMPK
In Vitro: PF-06409577 possesses similar potency toward the human and rat α1β1γ1 isoforms. In broad panel screening against other receptors, channels, PDEs and kinases, PF-06409577 exhibits minimal off-target pharmacology. PF-06409577 shows no detectable inhibition of hERG in a patch-clamp assay (100 μM) and is not an inhibitor (IC50>100 μM) of the microsomal activities of major human cytochrome P450 isoforms.
In Vivo: PF-06409577 demonstrates moderate plasma clearance in rats, dogs, and monkeys, and is well distributed with steady state distribution volume. Following oral administration of crystalline PF-06409577 in 0.5% methylcellulose suspension, PF-06409577 is rapidly absorbed in rats, dogs, and monkeys. The corresponding oral bioavailability values in rats, dogs, and monkeys, are 15%, 100%, and 59%, respectively. Dose responsive increases in pAMPK relative to total AMPK (tAMPK) in whole kidney tissue are observed with a maximal 3.8-fold response at 300 mg/kg PF-06409577 treatment. Oral administration of PF-06409577 (10, 30, and 100 mg/kg QD) results in dose-dependent reductions in proteinuria in the obese ZSF1 animals, with greater than 2-fold reduction in 24-hour urinary albumin loss compared to vehicle control after 60 days of treatment.
相关产品:Clinical Compound Library Plus | Bioactive Compound Library Plus | Epigenetics Compound Library | Kinase Inhibitor Library | PI3K/Akt/mTOR Compound Library | Clinical Compound Library | Anti-Aging Compound Library | Antioxidant Compound Library | Anti-diabetic Compound Library | Oxygen Sensing Compound Library | Glycolysis Compound Library | Cytoskeleton Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Obesity Compound Library | Lipid Metabolism Compound Library | Glucose Metabolism Compound Library | Targeted Diversity Library | Human Metabolite Library | Pain-Related Compound Library | Highly Selective Activators Library | ZLN024 | YLF-466D | Nepodin | AMPK activator 9 | Metformin-d6 hydrochloride | AMPK-IN-3 | HTH-01-015 | AMARA peptide TFA | LRRK2/NUAK1/TYK2-IN-1 | AMPK-IN-1 | AICAR | Metformin | BC1618 | BAY-3827 | Demethyleneberberine chloride | Chamaejasmine | Etilefrine | IM156 | Narazaciclib | Flufenamic acid-d4 | PF-739 | RSVA405 | MARK4 inhibitor 1 | Phenformin hydrochloride | MARK-IN-2 | Danthron | Galegine hydrochloride | Dorsomorphin | Gomisin J
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
货号: HY-103683
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。